Neuralink brain implant trial in second patient
Neuralink, a company owned by Elon Musk, has just received approval from the Food and Drug Administration (FDA) to implant its brain chips in a second patient. This step was taken after the company explained the fix of the electrode problem that limits the functionality of the device to the first human test subject.
Why is this important?
This step is a significant advance for the brain-computer interface device that is expected to treat future neurological disorders. With this technology, it is hoped that people with severe paralysis can control electronic devices only with their minds.
Latest News:
NeuraLink is looking for applications from other patients with quadriplegia to test whether this device allows one to perform tasks such as controlling mobile phones and computers. According to a Wall Street Journal report, the proposed improvements include embedding some of the device cable deeper into the brain.
first patient experience
The first patient, Noland Arbaugh, has shared his experience with the device. Arbaugh, 30, told “Good Morning America” that this device gave him the ability to control the computer almost completely with his mind. However, within a month after the operation, many threads of the device implanted in his brain were released, making it impossible to read most of the electrical signals used to translate his thoughts into action. About 15% of the yarn that remains in place is finally stable, and software changes help him recover a lot of device capabilities, which he then demonstrates in a live broadcast.
What’s next?
Competition with Synchron
Neuralink is not alone in this race. Synchron, a competitor to Neuralink, is preparing for large-scale clinical trials with the aim of obtaining commercial approval for their implants. This shows how serious the competition in the field of brain-computer interface technology is.
Collaboration with Mass General Brigham
Mass General Brigham has also launched collaborative efforts with stakeholders and the FDA to accelerate the development of implants. This collaboration is expected to accelerate the innovation and implementation of this technology into daily medical practice.
Implications of brain-computer interface technology
potential benefits
This technology has great potential to change the lives of people with neurological disorders. From the ability to control electronic devices to the possibility of recovery of motor functions, the brain-computer interface can open up new opportunities in treatment and rehabilitation.
challenges faced
However, there are many challenges to be faced. One of them is to ensure the stability and safety of the implant in the long term. As experienced by Noland Arbaugh, problems with electrode threads can limit the functionality of the device. Therefore, continuous improvement and technological development are key to success.
regulations and approvals
In addition to technical challenges, the regulatory aspect is also a significant obstacle. The process of obtaining approval from regulatory bodies such as the FDA requires substantial evidence of the safety and effectiveness of the device. Collaboration with organizations such as Mass General Brigham can help speed up this process.
economic and social implications
cost and accessibility
Advanced technology like this usually comes at a high cost. With prices that may reach thousands to hundreds of thousands of dollars (1 US dollar = around 16 thousand rupiah), accessibility for the general public is an important issue that needs to be overcome. Efforts are needed to make this technology more affordable and available to those in need.
social impact
In addition to the medical aspect, this technology also has a significant social impact. The ability to control electronic devices with the mind can change the way we interact with technology, opening up new opportunities in various fields such as education, work, and entertainment.
Conclusion
The NeuraLink trial of the second patient is an important step in the development of brain-computer interface technology. By continuing to make improvements and collaborating with various parties, it is hoped that this technology can immediately become a solution to various neurological problems and open up new opportunities in various aspects of life.
FAQ (Frequently Asked Questions)
What is Neuralink?
NeuraLink is a technology company that develops a brain-computer interface to treat neurological disorders and enables control of electronic devices with mind.
Who founded Neuralink?
Neuralink was founded by Elon Musk.
What is the purpose of this trial?
This trial aims to test whether Neuralink brain implants can help people with quadriplegia controlling electronic devices such as mobile phones and computers.
What was the problem found in the first trial?
In the first trial, many of the device’s electrode threads were detached, making them unable to read most of the electrical signals needed to translate the mind into action.
What repairs were made on the device?
Improvements include embedding multiple device cables deeper into the brain and making changes to the software to improve the stability and functionality of the device.
What makes this technology important?
This technology is important because it has the potential to treat neurological disorders, improve the quality of life for people with paralysis, and open up new opportunities in human interaction with technology.
What is the future of brain-computer interface technology?
The future of this technology is bright with a lot of research and development that is being carried out. However, technical and regulatory challenges still need to be addressed before these technologies can be widely adopted.
